Projekt

Daten zum Projekt

Overcoming Systematic Barriers that Undermine Access to Quality Lifesaving Antibiotics in Refugee Communities in Colombia, Lebanon and Uganda - Vorbereitungsmittel

Initiative: Globale Herausforderungen
Ausschreibung: Mobility - Global Medicine and Health Research
Bewilligung: 14.10.2020
Laufzeit: 9 Monate

Projektinformationen

The "temporariness" of forced displacement means exposure to many socioeconomic determinants that predispose migrants to negative health outcomes. While there are inter-country variations in the integration of refugees in the healthcare system, access to quality life-saving medicine is a global problem. Though the barriers to access are contextual, collective challenges remain for each of these settings with the common predictors poorly understood. To identify these predictors of access to poor quality medicines, this project aims to understand systems-level barriers and to identify specific interventions to address bottlenecks to accessing quality medicines, within three distinct study settings in Africa, the Middle East and South America. To limit the scope, the applicants are focusing on access to quality antibiotics - one of the most-commonly used medicines. The project proposes an embedded research approach, with active engagement and participation of key academic partners in Lebanon, Uganda and Colombia, refugees, international NGOs, local public health agencies and community groups in charge of refugee access to healthcare services in the host countries. In addition, the applicants will construct structured and semi-structured surveys with inputs from partners on the ground to identify the barriers to accessing quality antibiotics. Through surveys, they will also be able to identify methodological gaps in research practice that limit understanding of healthcare access among refugee communities.

Projektbeteiligte

  • Prof. Dr. Clarissa Prazeres da Costa

    Technische Universität München
    Fakultät für Medizin
    Center for Global Health
    Institut für Medizinische Mikrobiologie,
    Immunologie und Hygiene (MIH)
    München

  • Prof. Muhammad Zaman

    Boston University
    Howard Hughes Medical Institute
    Department of Biomedical Engineering and
    International Health
    Boston
    USA

  • Prof. Christopher Garimoi Orach

    Makerere University
    School of Public Health
    Department of Community Health and
    Behavioural Sciences
    Kampala
    Uganda

  • Aline Germani

    American University of Beirut
    Faculty of Health Sciences
    Center for Public Health Practice
    Beirut
    Libanon

  • Prof. Oscar Bernal

    University of los Andes
    School of Government
    Bogotá
    Kolumbien (Colombia)